Authors: AURICHE M BERTRAND P BLAY N DANAN G HAMEL JD IMBS JL LAGIER G MICALEFF A MOORE N OLLAGNIER M REVEILLEAURICHARD S SOUBRIE C WEBER F

Citation: M. Auriche et al., GOOD PHARMACOVIGILANCE PRACTICES AND PUBL ICATIONS OF CASE-REPORTS - DISCUSSIONS AND COMMENTS, Therapie, 52(2), 1997, pp. 123-127

Authors: SANMARCO JL JOUGLARD J THIRION X ALBERTINI F ARDITI J COULOUVRAT H DELAROZIERE JC GLEZER D MONIER S PRAT P SANTUCCI JJ SPADARI M TANCHE B LAGIER G

Citation: Jl. Sanmarco et al., ABUSE OF LAWFUL AND UNLAWFUL PSYCHOTROPIC -DRUGS - OPPIDUM, A 5-YEAR SURVEY OF CONSUMPTION IN A DRUG-ADDICT POPULATION IN MARSEILLES, Therapie, 51(5), 1996, pp. 586-598

Authors: ADVENIER C AVOUAC B BECHTEL P BOISSEL JP CALVO F JARDIN A LAGIER G LECHAT P MONTASTRUC JL PUECH A ROYER RJ THUILLEZ C TILLEMENT JP

Citation: C. Advenier et al., FIRST CONGRESS OF THE CIATION-FOR-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS, Therapie, 51(4), 1996, pp. 341-347

Authors: MOORE N NOBLET C KREFTJAIS C LAGIER G OLLAGNIER M IMBS JL

Citation: N. Moore et al., THE FRENCH PHARMACOVIGILANCE DATABASE SYS TEM - SOME EXAMPLES, Therapie, 50(6), 1995, pp. 557-562

Authors: LAGIER G

Citation: G. Lagier, RISKS RELATED TO DISCONTINUATION OF DRUGS - STUDY METHODS OTHER THAN CONTROLLED TRIALS, Therapie, 48(5), 1993, pp. 427-427

Authors: BRILLET G STEPHAN D IMBS JL ANDREJAK A BAUMELOU A BRIAND Y BRILLET G CARON J CHAUMETRIFFAUD M DERAY G DUBRAY C ESPIE J FRIEDLANDER G GROSSE R HAMEL JD IMBS JL KREFTJAIS C LAGIER G LAVILLE M MERLE L MORIN JP ROSSI A ROTHSCHILD E STEPHAN D TOUTAIN H WINICKI MJ

Citation: G. Brillet et al., MECHANISMS, PREDICTION AND PREVENTION OF DRUGS NEPHROTOXICITY, Therapie, 48(4), 1993, pp. 321-326